Literature DB >> 12423672

Effects of norepinephrine on rat cultured microglial cells that express alpha1, alpha2, beta1 and beta2 adrenergic receptors.

Kohji Mori1, Emi Ozaki, Bo Zhang, Lihua Yang, Akiko Yokoyama, Ikuko Takeda, Nobuji Maeda, Masahiro Sakanaka, Junya Tanaka.   

Abstract

Microglial cells rapidly become activated in response to even minor damage of neurons, suggestive of the intimate interactions between neurons and microglial cells. Although mediators for microglia-neuron interactions have not been well identified, neurotransmitters are possible candidates transmitting signals from neurons to microglial cells. Among the neurotransmitters, we focused on the effects of norepinephrine and other adrenergic agonists on the functions of rat cultured microglial cells. Reverse transcriptase polymerase chain reaction studies revealed that microglial cells expressed mRNAs encoding alpha1A, alpha2A, beta1 and beta2 receptors. Norepinephrine and a beta2 adrenergic agonist terbutaline elevated intracellular cAMP level of microglial cells. Norepinephrine, an alpha1 agonist phenylephrine, a beta1 agonist dobutamine and terbutaline suppressed the expressions of mRNAs encoding pro-inflammatory cytokines, interleukin-6 and tumor necrosis factor alpha. Release of tumor necrosis factor alpha and nitric oxide was suppressed by norepinephrine, phenylephrine, dobutamine and terbutaline. An alpha2 agonist clonidine and dobutamine upregulated the expression of mRNA encoding catechol-O-methyl transferase, an important enzyme to degrade norepinephrine. Norepinephrine, dobutamine and terbutaline upregulated the expressions of mRNA encoding 3-phospshoglycerate dehydrogenase, an essential enzyme for synthesis of L-serine and glycine, which are amino acids necessary for neuronal survival. Clonidine upregulated the expression of mRNA encoding an anti-apoptotic factor Bcl-xL. These results suggest that norepinephrine participates in the regulation of brain function at least partly by modulating the functions of microglia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12423672     DOI: 10.1016/s0028-3908(02)00211-3

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  64 in total

1.  Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine.

Authors:  Michael T Heneka; Fabian Nadrigny; Tommy Regen; Ana Martinez-Hernandez; Lucia Dumitrescu-Ozimek; Dick Terwel; Daniel Jardanhazi-Kurutz; Jochen Walter; Frank Kirchhoff; Uwe-Karsten Hanisch; Markus P Kummer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

2.  Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.

Authors:  Pooneh Memar Ardestani; Andrew K Evans; Bitna Yi; Tiffany Nguyen; Laurence Coutellier; Mehrdad Shamloo
Journal:  Neuropharmacology       Date:  2017-01-13       Impact factor: 5.250

Review 3.  Physical Exercise and Neuroinflammation in Major Depressive Disorder.

Authors:  Zuleide M Ignácio; Renato S da Silva; Marcos E Plissari; João Quevedo; Gislaine Z Réus
Journal:  Mol Neurobiol       Date:  2019-06-21       Impact factor: 5.590

Review 4.  Role of nonsynaptic communication in regulating the immune response.

Authors:  Zsolt Selmeczy; E Sylvester Vizi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Neurochem Int       Date:  2007-06-17       Impact factor: 3.921

5.  Lipopolysaccharide-induced down-regulation of Ca2+ release-activated Ca2+ currents (I CRAC) but not Ca2+-activated TRPM4-like currents (I CAN) in cultured mouse microglial cells.

Authors:  Andreas Beck; Reinhold Penner; Andrea Fleig
Journal:  J Physiol       Date:  2007-11-08       Impact factor: 5.182

6.  Dose-dependent effects of ladostigil on microglial activation and cognition in aged rats.

Authors:  Marta Weinstock; Corina Bejar; Donna Schorer-Apelbaum; Rony Panarsky; Lisandro Luques; Shai Shoham
Journal:  J Neuroimmune Pharmacol       Date:  2013-01-17       Impact factor: 4.147

7.  Features of the structure, development, and activity of the zebrafish noradrenergic system explored in new CRISPR transgenic lines.

Authors:  Matthew J Farrar; Kristine E Kolkman; Joseph R Fetcho
Journal:  J Comp Neurol       Date:  2018-10-15       Impact factor: 3.215

Review 8.  L-serine in disease and development.

Authors:  Tom J de Koning; Keith Snell; Marinus Duran; Ruud Berger; Bwee-Tien Poll-The; Robert Surtees
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

9.  Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment.

Authors:  Sudhirkumar U Yanpallewar; Kimberly Fernandes; Swananda V Marathe; Krishna C Vadodaria; Dhanisha Jhaveri; Karen Rommelfanger; Uma Ladiwala; Shanker Jha; Verena Muthig; Lutz Hein; Perry Bartlett; David Weinshenker; Vidita A Vaidya
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

10.  The contribution of the locus coeruleus-norepinephrine system in the emergence of defeat-induced inflammatory priming.

Authors:  Julie E Finnell; Casey M Moffitt; L Ande Hesser; Evelynn Harrington; Michael N Melson; Christopher S Wood; Susan K Wood
Journal:  Brain Behav Immun       Date:  2019-01-29       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.